Bangladesh imposes more restrictions on Rohingya refugees

Following failed repatriation attempts and the murder of a local politician, Bangladesh authorities are cracking down on Rohingya refugees.

The government of Bangladesh has recently put severe restrictions on Rohingya refugees from Myanmar.

Many have had their mobile phones taken away.

And some Rohingya children have been forced to drop out of Bangladeshi schools.

Al Jazeera’s Tanvir Chowdhury reports from Cox’s Bazar.

JPMorgan Chase CEO Jamie Dimon warns ‘there’s a recession ahead’

JPMorgan Chase CEO Jamie Dimon warned on Tuesday that a recession is on the horizon thanks to the continuing trade tensions with China.

“Of course there’s a recession ahead,” Dimon said during a morning call with reporters after the bank announced its third-quarter earnings.

“It does look like geopolitics, particularly around China and trade, are reducing business confidence and business capital expenditure,” Dimon added.

The comments come just days after President Trump announced the first phase of a trade deal with China that guarantees another $40 billion in purchases of US goods and will keep tariffs on Chinese imports.

The market reaction to the deal, which hasn’t been written and still needs to be signed, was muted on Monday, with markets about flat.

Businesses have been slowing hiring in recent months as the trade war has dragged on into its 18th month — with economists worried that that will hit consumers.

Dimon added that consumers haven’t shown the same worries that businesses have — especially since unemployment reached a 50-year low last month.

“The consumer is not under strain. The consumer is doing fine,” he said.

On Tuesday, JPMorgan announced that the bank’s profits rose 8 percent during the third quarter, to $9.1 billion, beating analysts’ expectations.

Surgeon dubbed Dr Daddy accused of running child sex ring found dead in cell

Charles Schwab Bottom Line Climbs In Q3

Charles Schwab (SCHW) announced a profit for its third quarter that advanced from the same period last year.

The company’s bottom line totaled $913 million, or $0.70 per share. This compares with $885 million, or $0.65 per share, in last year’s third quarter.

Analysts had expected the company to earn $0.64 per share, according to figures compiled by Thomson Reuters. Analysts’ estimates typically exclude special items.

The company’s revenue for the quarter rose 5.0% to $2.71 billion from $2.58 billion last year.

Charles Schwab earnings at a glance:

-Earnings (Q3): $913 Mln. vs. $885 Mln. last year.
-EPS (Q3): $0.70 vs. $0.65 last year.
-Analysts Estimate: $0.64
-Revenue (Q3): $2.71 Bln vs. $2.58 Bln last year.

Ireland U21 vs Iceland: Stephen Kenny's youngsters seek another qualifier victory

Stephen Kenny’s impressive Under-21 side continue their European Championship 2021 qualification campaign in Iceland but will be without Troy Parrott and Aaron Connolly for the game. Follow the action right here (kick-off 4pm).

The ‘most appalling night’ in English football

Can UEFA do anything to stamp out racism in football? Also today, Turkey says a ceasefire is “not an option” in northern Syria.

:: Listen to the Daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker

Aphria shares rocket 22% premarket after company posts surprise Q1 profit

U.S.-listed shares of Canadian cannabis company Aphria Inc. APHA, +26.38%APHA, +16.75% rose 22% in premarket trade Tuesday, after the company posted a profit for its fiscal first quarter, and not the loss that analysts were expecting. Leamington, Ontario-based Aphria said it had net income of C$16.4 million ($12.4 million), or 7 cents a share, after net income of C$21.2 million, or 9 cents a share, in the year-earlier period. The FactSet consensus was for a loss of 2 cents a share. Revenue came to C$126.1 million, up from C$13.3 million a year ago, but below the C$131.0 million FactSet consensus. Revenue was below the C$128.6 million posted for the fourth quarter, due to a change in business strategy at CC Pharma to maximize profitability after recent changes in the German government’s medical reimbursement model. The company sold more than 3,317 kg equivalents in the adult-use market and 1,354 kg equivalents in the medical cannabis market. The average retail selling price before excise tax fell to C$7.56 from C$7.66 in the prior quarter, mostly due to a higher percentage of medical cannabis sales. The company said it still expects fiscal 2020 revenue of about C$650 million to C$700 million. Shares have fallen 24% in 2019 through Monday, while the ETFMG Alternative Harvest ETF MJ, +6.74% has fallen 26% and the S&P 500 SPX, +0.99% has gained 18%.

Brunswick boosts dividend by 14%, stock jumps toward 11-month high

Brunswick Corp. BC, +1.64% said Tuesday it has raised its quarterly dividend by 14%, to 24 cents a share from 21 cents a share. The boat and engines maker said the new dividend will be payable Dec. 13 to shareholders of record on Nov. 19. The stock rose 1.6% in midday trading, putting them on track to close at the highest level since Nov. 26, 2018. Based on current prices, the new annual dividend rate implies a dividend yield of 1.76%, compared with the implied yield for the S&P 500 SPX, +1.07% of 1.97%. The company said it has now increased its dividend for seven consecutive years. "The strong and steady profitability of our Parts & Accessories business and its aftermarket revenue, along with our focus on product leadership, operational excellence, and the structural changes we’ve made to leverage our scale across our marine businesses position us well for the future," said Chief Executive David Foulkes. The stock has run up 17% year to date, while the S&P 500 SPX, +1.07% has climbed 20%.